Tim Van Assche is a Business Development Director at eTheRNA immunotherapies, an mRNA-LNP platform company providing end-to-end solutions for next generation mRNA therapeutics. Before his BD role, Tim supported the development of mRNA-based products as a clinical study and program leader.
Prior to joining eTheRNA, Tim was a clinical research professional at a CRO, where he managed clinical studies in oncology, immunology, pulmonology, cardiology and infectious diseases for small biotech as well as large pharma companies.
Next to his extensive expertise in drug development, Tim also has a broad academic research background. After his PhD at the University of Antwerp, he held postdoctoral research positions at the University of Oxford, the Université Catholique de Louvain and the University of Antwerp studying cardiovascular and infectious diseases.
